DataMEDS AI reports 50% sequential revenue growth and reinstates Nasdaq listing
DataMEDS AI reported a 50% sequential revenue increase to $2.7 million, a net profit, and regained Nasdaq listing compliance as it expands through new partners and acquisitions.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed